Trials / Unknown
UnknownNCT06229756
Clinical Results of Asqelio™ EDOF Toric Soft Hydrophobic Intraocular Lens After Cataract Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- AST Products, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to assess the clinical outcomes of binocular implantation of Asqelio EDOF Toric IOLs in healthy cataract patients. The main questions it aims to answer are: * What is the visual performance at different distances 3 months after implantation of Asqelio EDOF Toric in both eyes? * What is the amount of residual refractive error following the implantation? * What is the contrast sensitivity of patients 3 months after implantation of Asqelio EDOF Toric in both eyes? * What is the optical quality of the eye implanted with Asqelio EDOF Toric IOL? * What is the incidence and severity of visual symptoms after implantation of Asqelio EDOF Toric? * What is the level of patient satisfaction after implantation of Asqelio EDOF Toric? For this purpose, participants will be submitted to a comprehensive visual and refractive assessment, following common clinical practice, 3 months after binocular implantation of Asqelio EDOF Toric IOLs, and asked to complete visual symptoms and patient satisfaction questionnaires.
Conditions
Timeline
- Start date
- 2022-10-26
- Primary completion
- 2024-03-01
- Completion
- 2024-04-01
- First posted
- 2024-01-29
- Last updated
- 2024-01-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06229756. Inclusion in this directory is not an endorsement.